← Every company

Inovio Pharmaceuticals Inc SEC Filings

What Inovio Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

INO overview →
Filings on file
110
since Oct 14, 2016
Warning signs
1
latest Nov 2, 2023
Last results
Aug 12, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 12, 2026
Results announced
8-K
Read ↗
Aug 12, 2026
Quarterly report
10-Q
Read ↗
Jul 31, 2026
Material agreement
8-K
Read ↗
Jul 29, 2026
Results announced
8-K
Read ↗
May 20, 2026
Shareholder vote
8-K
Read ↗
May 13, 2026
Results announced
8-K
Read ↗
May 13, 2026
Quarterly report
10-Q
Read ↗
Apr 6, 2026
Material agreement
8-K
Read ↗
Mar 12, 2026
Results announced
8-K
Read ↗
Mar 12, 2026
Annual report
10-K
Read ↗
Jan 27, 2026
Material agreement
8-K
Read ↗
Nov 12, 2025
Material agreement
8-K
Read ↗
Nov 10, 2025
Results announced
8-K
Read ↗
Nov 10, 2025
Quarterly report
10-Q
Read ↗
Aug 12, 2025
Results announced
8-K
Read ↗
Aug 12, 2025
Quarterly report
10-Q
Read ↗
Jul 7, 2025
Material agreement
8-K
Read ↗
May 22, 2025
Shareholder vote
8-K
Read ↗
May 13, 2025
Results announced
8-K
Read ↗
May 13, 2025
Quarterly report
10-Q
Read ↗
Mar 18, 2025
Results announced
8-K
Read ↗
Mar 18, 2025
Annual report
10-K
Read ↗
Dec 16, 2024
Material agreement
8-K
Read ↗
Nov 14, 2024
Results announced
8-K
Read ↗
Nov 14, 2024
Quarterly report
10-Q
Read ↗
Aug 13, 2024
Material agreement
8-K
Read ↗
Aug 8, 2024
Results announced
8-K
Read ↗
Aug 8, 2024
Quarterly report
10-Q
Read ↗
May 28, 2024
Executive or director changeShareholder vote
8-K
Read ↗
May 13, 2024
Results announced
8-K
Read ↗
May 13, 2024
Quarterly report
10-Q
Read ↗
Apr 17, 2024
Material agreement
8-K
Read ↗
Mar 6, 2024
Annual report
10-K
Read ↗
Jan 12, 2024
Shareholder vote
8-K
Read ↗
Nov 9, 2023
Results announced
8-K
Read ↗
Nov 9, 2023
Quarterly report
10-Q
Read ↗
Nov 2, 2023
Delisting notice or listing transfer
8-K
Read ↗
Aug 9, 2023
Results announced
8-K
Read ↗
Aug 9, 2023
Quarterly report
10-Q
Read ↗
Aug 1, 2023
Restructuring
8-K
Read ↗
May 18, 2023
Executive or director changeShareholder vote
8-K
Read ↗
May 10, 2023
Results announced
8-K
Read ↗
May 10, 2023
Quarterly report
10-Q
Read ↗
Mar 1, 2023
Annual report
10-K
Read ↗
Mar 1, 2023
Results announced
8-K
Read ↗
Jan 31, 2023
Restructuring
8-K
Read ↗
Nov 8, 2022
Results announced
8-K
Read ↗
Nov 8, 2022
Quarterly report
10-Q
Read ↗
Aug 9, 2022
Results announced
8-K
Read ↗
Aug 9, 2022
Quarterly report
10-Q
Read ↗
Jul 19, 2022
Restructuring
8-K
Read ↗
May 17, 2022
Executive or director changeShareholder vote
8-K
Read ↗
May 10, 2022
Executive or director changeResults announced
8-K
Read ↗
May 10, 2022
Quarterly report
10-Q
Read ↗
Mar 1, 2022
Annual report
10-K
Read ↗
Nov 9, 2021
Quarterly report
10-Q
Read ↗
Oct 29, 2021
Material agreement
8-K
Read ↗
Aug 9, 2021
Quarterly report
10-Q
Read ↗
Jun 11, 2021
Material agreement
8-K
Read ↗
May 17, 2021
Executive or director changeShareholder vote
8-K
Read ↗
May 10, 2021
Quarterly report
10-Q
Read ↗
Mar 1, 2021
Results announced
8-K
Read ↗
Mar 1, 2021
Annual report
10-K
Read ↗
Jan 22, 2021
Material agreement
8-K
Read ↗
Jan 20, 2021
Results announced
8-K
Read ↗
Jan 4, 2021
Material agreement
8-K
Read ↗
Nov 9, 2020
Quarterly report
10-Q
Read ↗
Oct 15, 2020
Material agreement
8-K
Read ↗
Sep 3, 2020
Executive or director change
8-K
Read ↗
Aug 10, 2020
Quarterly report
10-Q
Read ↗
Jun 25, 2020
Material agreement
8-K
Read ↗
May 18, 2020
Shareholder vote
8-K
Read ↗
May 11, 2020
Quarterly report
10-Q
Read ↗
Apr 3, 2020
Material agreement
8-K
Read ↗
Mar 12, 2020
Annual report
10-K
Read ↗
Mar 9, 2020
Results announcedMaterial agreement
8-K
Read ↗
Feb 7, 2020
Material agreement
8-K
Read ↗
Jan 15, 2020
Executive or director change
8-K
Read ↗
Jan 2, 2020
Material agreement
8-K
Read ↗
Nov 12, 2019
Quarterly report
10-Q
Read ↗
Aug 8, 2019
Quarterly report
10-Q
Read ↗
Aug 6, 2019
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Jul 16, 2019
Restructuring
8-K
Read ↗
May 10, 2019
Executive or director changeShareholder vote
8-K
Read ↗
May 9, 2019
Quarterly report
10-Q
Read ↗
Mar 25, 2019
Executive or director change
8-K
Read ↗
Mar 12, 2019
Executive or director change
8-K
Read ↗
Mar 12, 2019
Annual report
10-K
Read ↗
Feb 26, 2019
Executive or director change
8-K
Read ↗
Feb 20, 2019
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Feb 13, 2019
Results announced
8-K
Read ↗
Jan 3, 2019
Executive or director change
8-K
Read ↗
Nov 8, 2018
Quarterly report
10-Q
Read ↗
Aug 7, 2018
Quarterly report
10-Q
Read ↗
May 25, 2018
Material agreement
8-K
Read ↗
May 14, 2018
Shareholder vote
8-K
Read ↗
May 9, 2018
Quarterly report
10-Q
Read ↗
Mar 14, 2018
Annual report
10-K
Read ↗
Jan 2, 2018
Material agreement
8-K
Read ↗
Dec 6, 2017
Executive or director change
8-K
Read ↗
Nov 8, 2017
Quarterly report
10-Q
Read ↗
Aug 8, 2017
Quarterly report
10-Q
Read ↗
Jul 18, 2017
Results announced
8-K
Read ↗
May 16, 2017
Executive or director changeShareholder vote
8-K
Read ↗
May 10, 2017
Quarterly report
10-Q
Read ↗
Mar 24, 2017
Executive or director change
8-K
Read ↗
Mar 15, 2017
Annual report
10-K
Read ↗
Mar 9, 2017
Executive or director change
8-K
Read ↗
Nov 9, 2016
Quarterly report
10-Q
Read ↗
Oct 14, 2016
Material agreementNew debt
8-K
Read ↗

Source: Inovio Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on INO

Related datasets